Mapping decision-making pathways: Determination of intervention entry points for diagnostic tests in suspected serious infection

Naseem, R ORCID: 0000-0003-1978-4370, Howe, N ORCID: 0000-0001-9446-8314, Pretorius, S ORCID: 0000-0001-8277-711X, Williams, C, Lendrem, C, Pallmann, P ORCID: 0000-0001-8274-9696 and Carrol, ED ORCID: 0000-0001-8357-7726 (2025) Mapping decision-making pathways: Determination of intervention entry points for diagnostic tests in suspected serious infection Nihr Open Research, 4. 35-. ISSN 2633-4402, 2633-4402

Access the full-text of this item by clicking on the Open Access link.

Abstract

Background: PROTECT (Platform Randomised evaluation of clinical Outcomes using novel TEChnologies to optimise antimicrobial Therapy) has brought together a team of researchers to design a platform trial to rapidly evaluate and adopt into care multiple diagnostic technologies, bringing immediate benefit to patients. Rapid diagnostic tests will be used to identify patients at risk of deterioration from severe infection, before they become critically unwell. The platform will assess their comparative clinical effectiveness and cost-effectiveness relative to current standard of care. Preliminary work, conducted under a Health Technology Assessment Application Acceleration Award, provided key evidence to optimise the design of the PROTECT platform. Methods: Qualitative methods which involved consulting key stakeholders in the field of serious infection addressed the key priorities. A high-level care pathway analysis focusing on serious infection in secondary care, captured the points of contact, actions, decisions, and potential outcomes associated with a patient’s care. Results: Two use cases of rapid diagnostic tests for serious infection were identified; (1) in acute emergency medicine to decide on antimicrobial initiation and/or escalation of care, and (2) in hospitalised patients to monitor treatment response. The “ideal” test should be rapid, point-of-care, cheap to procure, have capacity for high usability, and ability to be performed and interpreted by all staff. Facilitators to the adoption of infection diagnostic tests is their clinical need, and the main potential barrier is poor change management and behavioural change. Conclusions: Any new test should provide robust evidence of its clinical effectiveness and have the potential to accelerate ruling in or out serious infection which benefits the clinical pathway for patients, clinicians, and hospitals as a whole, to be considered for adoption as a new standard of care.

Item Type:	Article
Uncontrolled Keywords:	PROTECT study team
Divisions:	Faculty of Health & Life Sciences Faculty of Health & Life Sciences > Inst. Infection, Vet & Ecological Sciences
Depositing User:	Symplectic Admin
Date Deposited:	17 Mar 2025 09:11
Last Modified:	23 Jan 2026 18:09
DOI:	10.3310/nihropenres.13568.2
Open Access URL:	https://openresearch.nihr.ac.uk/articles/4-35
Related Websites:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3190840
Disclaimer:	The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.